The study design was a non-inferiority trial and for calculating the sample size, results of a similar study (Matan Elami-Suzin et al., 2013) [14] were considered. These authors showed that the abortion rate using mifepristone followed by misoprostol or oxytocin for the second-trimester abortion was 100% and 95.8%, respectively. Assuming that similar success rates would be obtained for the present study, a difference of 2% between the groups is clinically negligible, with the 5% level of significance (one-tailed) and power of 80%, a sample size of 60 in each group was considered to be sufficient to prove equivalence. The sample size calculation was done using the R-software version 3.24.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.